COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $168 | +7.7% | 45,010 | +97.9% | 0.01% | +18.2% |
Q1 2023 | $156 | -20.0% | 22,741 | -7.5% | 0.01% | -31.2% |
Q4 2022 | $195 | -99.9% | 24,587 | +33.1% | 0.02% | -5.9% |
Q3 2022 | $178,000 | -5.3% | 18,473 | -28.9% | 0.02% | 0.0% |
Q2 2022 | $188,000 | +8.0% | 25,990 | +92.7% | 0.02% | +183.3% |
Q1 2022 | $174,000 | – | 13,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |